Fig. 5: Details of interactions between SARS-CoV-2 RBD and mAbs. | Nature Communications

Fig. 5: Details of interactions between SARS-CoV-2 RBD and mAbs.

From: Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants

Fig. 5

a, b CDR loops of 13G9 Fab (a, left) and 58G6 Fab (b, left) overlaid on the surface representation of RBD (shown as pink and magenta, respectively), and surface representations of 13G9 epitope (a, right, red) and 58G9 epitope (b, right, red and blue) on the RBD surface. c, d The hydrogen bonds at the binding interface between 13G9 (left) or 58G6 (right) and SARS-CoV-2 RBD.

Back to article page